ASX News
Immutep reports strong response rate from immunotherapies treating carcinomas
Immutep Ltd has reported a slew of positive results from a trial to assess a combination of immunotherapy cancer drugs.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| CYA | Ann: Calculation of Scheme Consideration | 12/04/19 | 8 | 4.9K | |||
|
|||||||
| CYA | Ann: Removal from the Official List | 06/03/19 | 0 | 3.2K | |||
|
|||||||
| CYA | Ann: WLE: WLE and CYA merger implemented and Appendix 3B | 05/03/19 | 0 | 929 | |||
|
|||||||
| CYA | Ann: Final Director's Interest Notice - S Menzies | 05/03/19 | 0 | 1.2K | |||
|
|||||||
| CYA | Ann: Final Director's Interest Notice - R Turner | 05/03/19 | 0 | 1.1K | |||
|
|||||||
| CYA | Ann: Change of Director's Interest Notice - S Menzies | 05/03/19 | 0 | 565 | |||
|
|||||||
| CYA | Ann: Change of Director's Interest Notice - R Finley | 05/03/19 | 0 | 1.2K | |||
|
|||||||
| CYA | Ann: Change of Director's Interest Notice - R Turner | 05/03/19 | 0 | 507 | |||
|
|||||||
See All Discussions
